Evidence map›Paper›PMID 38753807›Full record

ArticlePloS one2024

Exploring consumer preferences for cannabis edible products to support public health policy: A discrete choice experiment.

Jennifer Donnan, Karissa Johnston, Michael Coombs, Maisam Najafizada, Lisa Bishop

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jennifer DonnanSchool of Pharmacy, Memorial University, St. John's, Newfoundland and Labrador, Canada.ORCID 0000-0002-2908-0804
Karissa JohnstonSchool of Pharmacy, Memorial University, St. John's, Newfoundland and Labrador, Canada.
Michael CoombsSchool of Pharmacy, Memorial University, St. John's, Newfoundland and Labrador, Canada.
Maisam NajafizadaFaculty of Medicine, Memorial University, St. John's, Newfoundland and Labrador, Canada.
Lisa BishopSchool of Pharmacy, Memorial University, St. John's, Newfoundland and Labrador, Canada.ORCID 0000-0002-4979-4222

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn October 2019, cannabis edibles were legalized for sale in Canada for non-medical use. This move was intended to improve public safety by regulating contents (including a maximum 10 mg tetrahydrocannabinol (THC) per package) and packaging to prevent accidental ingestion or over consumption. This study aimed to explore consumer preferences for cannabis edibles to inform cannabis policy.

methodsWe explored the relative importance and trade-offs consumers make for attributes of cannabis edibles using a discrete choice experiment. Attributes included type of edible, price, THC content, cannabis taste, package information, product consistency, product recommendations, and Health Canada regulation. Participants lived in Canada, were 19 years of age or older, and purchased a cannabis edible in the last 12 months. A multinomial logit (MNL) model was used for the base model, and latent class analysis to assess preference sub-groups. This study was approved by the institutional ethics committee.

resultsAmong 684 participants, the MNL model showed that potency was the most relevant attribute, followed by edible type. A two-group latent class model revealed two very distinct preference patterns. Preferences for group 1 (~65% of sample) were driven primarily by edible type, while for group 2 (~35% of sample) were driven almost entirely by THC potency.

conclusionThis study found that consumer preferences for ~65% of consumers of cannabis edibles are being met through regulated channels. The remaining ~35% are driven by THC potency at levels that are not currently available on the licensed market. Attracting this market segment will require reviewing the risks and benefits of restricting THC package content.

Indexed as

CannabisChoice BehaviorConsumer BehaviorDronabinolAdultCanadaFemaleHealth PolicyHumansMaleMiddle AgedPublic HealthYoung AdultDronabinol

Identifiers

PMID38753807
PMCPMC11098505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.